Cleared Special

K093303 - SCOUTPRO 7F LONG CATHETERS

K093303 is the FDA 510(k) clearance for SCOUTPRO 7F LONG CATHETERS by Biotronik, Inc.. It is a Class 2 Cardiovascular device (product code DQY) cleared through the Special 510(k) pathway after a 30-day FDA review.

K093303 · Biotronik, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2009
Decision
30d
Days
Class 2
Risk

K093303 is an FDA 510(k) clearance for the SCOUTPRO 7F LONG CATHETERS. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Biotronik, Inc. (Lake Oswego, US). The FDA issued a Cleared decision on November 20, 2009 after a review of 30 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Biotronik, Inc. devices

Submission Details

510(k) Number K093303 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 21, 2009
Decision Date November 20, 2009
Days to Decision 30 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
95d faster than avg
Panel avg: 125d · This submission: 30d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 547
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K093303.
ACUITY BREAK-AWAY GUIDE CATHETER
K093969 · Cardiac Pacemakers, Inc. · Mar 2010
ASAHI ZENYTEEX GUIDING CATHETER
K091188 · Asahi Intecc Co., Ltd. · Feb 2010
ARROW SELDINGER ARTERIAL CATHERIZATION DEVICES, MODELS EX SAC 00520
K093050 · Arrow Intl., Inc. · Dec 2009
ENVOY GUIDING CATHETERS
K093184 · Codman & Shurtleff, Inc. · Nov 2009
MODIFICATION TO MODIFIED HD GUIDE CATHETER
K092298 · Concentric Medical, Inc. · Nov 2009
HEADWAY 21 MICROCATHETER, MODEL: MC212150S
K093160 · MicroVention, Inc. · Nov 2009